J.H. Meerwaldt

Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987

M Tubiana, M. Henry‐Amar, Patrice Carde et al. · Blood · 1989 · 261 citations · Full text

Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.

Patrice Carde, Anton Hagenbeek, M. Hayat et al. · Journal of Clinical Oncology · 1993 · 209 citations

Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group.

Ivana Teodorović, Stefania Pittaluga, Hanneke C. Kluin‐Nelemans et al. · Journal of Clinical Oncology · 1995 · 156 citations

Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols

M. Henry‐Amar, M. Hayat, J.H. Meerwaldt et al. · International Journal of Radiation Oncology*Biology*Physics · 1990 · 101 citations

Oncology, Early Stage Hodgkin, Immunodeficiencies +4

Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the Working Formulation

Stefania Pittaluga, Luc Bijnens, Ivana Teodorović et al. · Blood · 1996 · 100 citations · Full text